-
An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder.
Covey LS, Hu M, Green CA, Brigham GS, Hurt RD, Adler LA, Winhusen TJ. An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder. American Journal of Drug and Alcohol Abuse 2011;37(5):392-399.
-
How practice and science are balanced and blended in the NIDA Clinical Trials Network: The bidirectional process in the development of the STAGE-12 protocol as an example.
Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Floyd AS. How practice and science are balanced and blended in the NIDA Clinical Trials Network: The bidirectional process in the development of the STAGE-12 protocol as an example. American Journal of Drug and Alcohol Abuse 2011;37(5):408-416.
-
Modeling site effects in the design and analysis of multi-site trials.
Feaster DJ, Mikulich-Gilbertson SK, Brincks AM. Modeling site effects in the design and analysis of multi-site trials. American Journal of Drug and Alcohol Abuse 2011;37(5):383-391.
-
Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: Results from the Clinical Trials Network.
Pilowsky DJ, Wu L, Burchett B, Blazer DG, Woody GE, Ling W. Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: Results from the Clinical Trials Network. Substance Abuse and Rehabilitation 2011;2:133-144.
-
A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.
Rieckmann TR, Kovas AE, McFarland BH, Abraham AJ. A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment. Journal of Substance Abuse Treatment 2011;41(4):374-385.
-
Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial.
Back SE, Payne R, Wahlquist AH, Carter RE, Stroud Z, Haynes LF, Hillhouse M, Brady KT, Ling W. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. American Journal of Drug and Alcohol Abuse 2011;37(5):313-323.
-
Some considerations for excess zeroes in substance abuse research.
Bandyopadhyay D, DeSantis SM, Korte JE, Brady KT. Some considerations for excess zeroes in substance abuse research. American Journal of Drug and Alcohol Abuse 2011;37(5):376-382.
-
Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED).
Bogenschutz MP, Donovan DM, Adinoff BH, Crandall C, Forcehimes AA, Lindblad R, Mandler RN, Oden NL, Perl HI, Walker NR. Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED). American Journal of Drug and Alcohol Abuse 2011;37(5):417-425.
-
Conducting research with racial/ethnic minorities: Methodological lessons from the NIDA Clinical Trials Network.
Burlew AK, Weekes JC, Montgomery L, Feaster DJ, Robbins MS, Rosa CL, Ruglass LM, Venner KL, Wu L. Conducting research with racial/ethnic minorities: Methodological lessons from the NIDA Clinical Trials Network. American Journal of Drug and Alcohol Abuse 2011;37(5):324-332.
-
Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerations.
Calsyn DA, Campbell ANC, Tross S, Hatch-Maillette MA. Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerations. American Journal of Drug and Alcohol Abuse 2011;37(5):294-300.